Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Keros Therapeutics (KROS) Cash from Investing Activities (2019 - 2025)

Keros Therapeutics filings provide 7 years of Cash from Investing Activities readings, the most recent being -$134000.0 for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities rose 53.63% to -$134000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.6 million, a 19.68% increase, with the full-year FY2025 number at -$1.6 million, up 19.68% from a year prior.
  • Cash from Investing Activities hit -$134000.0 in Q4 2025 for Keros Therapeutics, down from -$132000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$132000.0 in Q3 2025 to a low of -$1.1 million in Q1 2023.
  • Median Cash from Investing Activities over the past 5 years was -$331000.0 (2022), compared with a mean of -$410550.0.
  • Biggest five-year swings in Cash from Investing Activities: plummeted 1721.43% in 2021 and later skyrocketed 65.8% in 2025.
  • Keros Therapeutics' Cash from Investing Activities stood at -$159000.0 in 2021, then plummeted by 120.75% to -$351000.0 in 2022, then crashed by 54.13% to -$541000.0 in 2023, then skyrocketed by 46.58% to -$289000.0 in 2024, then surged by 53.63% to -$134000.0 in 2025.
  • The last three reported values for Cash from Investing Activities were -$134000.0 (Q4 2025), -$132000.0 (Q3 2025), and -$720000.0 (Q2 2025) per Business Quant data.